New York State’s Department of Labor this month released FAQ guidance pertaining to the state's legal use of cannabis by adults 21 or older. According to the guidance, employers are prohibited from discriminating against an employee for using "cannabis...
By guest contributors Bill Judge, JD, LL.M., and Nick Hartman of the Drug Screening Compliance Institute State and local marijuana laws around the country are fast-changing and often confusing. In this article NDASA members Bill Judge and Nick Hartman take on recent...
The Institute for Behavior and Health, Inc., is a nonprofit organization based in Rockville, Md., that develops strategies to reduce drug use. President Robert L. DuPont, M.D., was the lead author on an extensive 2015 report titled, “Workplace Drug Testing in the Era...
“We want to make it perfectly clear that the state initiatives will have no bearing on the Department of Transportation’s regulated drug testing program. The Department of Transportation’s Drug and Alcohol Testing Regulation – 49 CFR Part 40 – does not authorize the...
“Medical Review Officers will not verify a drug test as negative based upon information that a physician recommended that the employee use “medical marijuana.” Please note that marijuana remains a drug listed in Schedule I of the Controlled Substances Act. It remains...
“Don’t Drop Marijuana” explains why marijuana and THC, the active ingredient of the cannabis plant, should not be dropped from drug-testing programs and panels. Please click here to review the video on Vimeo.com. This video is produced by Drug Free Business, a...
The National Marijuana Initiative (NMI) is one of three national initiatives within the federal High Intensity Drug Trafficking Areas (HIDTA) Program. The White House Office of National Drug Control Policy has established HIDTA task forces all over the country to...
This is a quick-hit handout designed to promote understanding about CBD, an ingredient of the cannabis plant. To download this guide in a .pdf file format, please click here. CBD There is currently NO over-sight by the U.S. Food & Drug Administration of the CBD...
Marijuana is an impairing substance. The user experiences reduced motor coordination, short-term memory loss and altered reaction time, all of which has destructive effects in the workplace. High doses of THC, the active ingredient in the cannabis plant, can cause...
By NDASA member William Judge, JD, LL.M., founder of the Drug Screening Compliance Institute and an attorney with more than three decades of experience in drug screening compliance. New York, this week, became the 15th state (in addition to Washington D.C.) to...